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ABSTRACT
Neuromyelitis optica (NMO) also known as Devic’s disease is an acute demyelinating disorder combined with optic 
neuritis and transverse myelitis.A 10 years old boy presented in the ER with the complaints of fever and back pain for 
past 10 days and inability to walk for 6-7 days. He had developed urinary retention and constipation for the past 5 
days along with abdominal distension. There was also blurring of vision in the left eye with only light perception and 
rapid afferent papillary defect was present while the right eye was normal. The provisional diagnosis was Transverse 
myelitis vsNeuromyelitisoptica (NMO). CSF revealed TLC 4, protein 54mg/dl, glucose 66mg/dl. Oligoclonal bands were 
negative. There was raised CPK. Visual evoked potential (VEP) showed prolongation of P100 latency along with 
amplitude loss, in left eye.His MRI spine showed extensive involvement of the spinal cord especially the cervical cord 
and there was no involvement of the brain. Left eye had optic neuritis.He was treated with steroid pulse therapy and 
later Plasmapharesis and was discharged home on azathioprine with no motor deficit but the visual loss was 
irreversible
KEY WORDS:  optic neuritis, myelitis, Devic’s disease
C A S E  R E P O R T
INTRODUCTION 
Neuromyelitis optica (NMO) also known as Devic’s 
disease is an acute demyelinating disorder comprising 
of optic neuritis and transverse myelitis.1 NMO 
predominantly affects middle aged adults, while case 
reports from the pediatric population have been 
increasing in past few years. A recent case series of 
pediatric NMO revealed strong female predominance2. 
NMO has specific diagnostic criteria and unique 
pathologic features when compared with multiple 
sclerosis (MS) 3. Pediatric NMO has comparatively 
poor visual and motor outcomes.1Traditionally, the 
term NMO was applied to those patients who 
experienced a monophasic event consisting of bilateral 
simultaneous optic neuritis and acute myelitis.4
CASE REPORT
A 10 years old boy presented in the ER with the 
complaints of fever and back pain for past 10 days and 
inability to walk for 6-7 days. He had developed urinary 
retention and constipation for the past 5 days along 
with abdominal distension. For the past two days he 
had been complaining of blurring of vision in the left 
eye. There was no history of any recent viral illness, 
vaccination or trauma. He had been to a hospital 
where he was catheterized and started on broad 
spectrum antibiotics for the past 4 days but there was 
no improvement they came to this hospital.
 His birth and development was normal and he was a 
student of class III. There was no history of any 
allergies or surgery. Immunization was up to date. 
Family history included two sisters and three brothers 
who were well and healthy. There was no family history 
for any neurological disease or unexplained visual loss.
On examination the patient was fully alert, interactive 
and oriented. His anthropometric measures were on 
the 50th centile. He was afebrile, with stable vitals. 
There was no rash or lymphadenopathy. He was well 
hydrated and well nourished. His chest was clear with 
normal vesicular breathing while abdomen was full with 
slit like umbilicus and urinary bladder was palpable at 
the level of umbilicus, there was no shifting dullness or 
visceromegaly and gut sounds were audible. His GCS 
was 15/15 and higher mental functions were intact. 
Cranial nerves were intact. Tone was normal in all four 
limbs; power was 4/5 in both upper limbs and 1/5 in 
lower limbs. Deep tendon reflexes in upper limbs were 
+2 and in lower limbs +3. Planters were up going. 
Superficial reflexes were absent. On sensory 
examination pain, temperature, vibration and 
proprioception were intact. There were no signs of 
meningeal irritation. He was unable to sit and 
complained of pain on movement. His left eye had only 
light perception and showed rapid afferent papillary 
defect while the right eye was normal
The provisional diagnosis was Transverse myelitis 
vsNeuromyelitisoptica (NMO). Complete blood count 
and basic metabolic workup was normal. Inflammatory 
markers (C- reactive proteins and Erythrocyte 
sedimentation rate) were within normal limits. CSF 
revealed TLC 4, protein 54mg/dl, glucose 66mg/dl. 
Oligoclonal bands were negative. There was raised 
CPK. Visual evoked potential (VEP) showed 
prolongation of P100 latency along with amplitude 
loss, in left eye.MRI revealed multiple abnormal T2 
hyper intense signals showing post contrast 
enhancement almost along the entire spinal cord. 
These were predominately identified in the cervical 
region of the spinal cord along with swelling of the cord 
in this region. Overall appearance was suggestive of 
transverse myelitis. Bilateral globes and optic nerve 
appeared unremarkable. The grey matter and white 
matter appeared normalA diagnosis of Devic's disease 
was made and the patient was treated initially with 
intravenous methyl prednisolone (30 mg/kg/day for five 
days) followed by gradually tapered oral steroids. 
Condition of child remained static; therefore 
Plasmapharesis was done for 5 days. Azathioprine 2 
mg/kg/day was added and limb physiotherapy started. 
Clinical outcome was favorable with significant 
reversible of power and function of limbs. 
Discussion
By definition NMO is a monophasic or relapsing 
disorder of the optic nerves and the spinal cord, 
without evidence of white matter dysfunction of the 
brain, brainstem or cerebellum, with the exception of 
hypothalamic and lower brainstem dysfunction. Optic 
nerve and spinal cord dysfunction might be partial and 
it can be unilateral or even subclinical, with an 
abnormal visual evoked potential but no clinical signs. 
Partial forms of NMO are also called high-risk NMO, in 
which isolated transverse myelitis or optic neuritis 
occurs. The optico-spinal form of MS is quite similar to 
NMO. Hence, it appears to be a spectrum of NMO, with 
various degrees of involvement but course of NMO is 
more acute, sometimes fulminant. In contrastwith the 
optic neuritis of MS, NMO optic neuritis can be severe, 
fulminant and devastating with very poor 
prognosis.5Brain lesions have been observed in 
children; in one series 68% of NMO-IgG seropositive 
children and among them 45% had brain symptoms 
which corresponding to the MRI abnormalities6. In 
contrast to MS, attacks in NMO commonly spare the 
brain in the early stages. Hence, normal brain MRI is a 
common finding at the onset of NMO, so on follow-up 
scans must be performed periodically for development 
of later lesions in the course of the disease.4   Lesions 
in the Spinal cord are large, and extends over three or 
more vertebral segments in about 85-90% of patients 
and are mostly located in the cervical and upper 
thoracic region. The Current revised diagnostic criteria 
of NMO tells the presence of acute optic neuritis and 
myelitis with at least two of the three supportive 
criteria, which consist of spinal cord MRI lesion 
extending over three consecutive vertebral segments, 
brain MRI lesion, which does not meet the diagnostic 
criteria for multiple sclerosis, and NMO-IgG 
seropositive status.Our patient had no systemic 
disorder or non-organ-specific autoimmune disorder or 
autoantibody. At the time of the left eye's involvement, 
our patient fulfilled the diagnostic criteria.7 CSF 
examination of our patient showed no pleocytosis. 
Oligoclonal bands of IgG in the CSF are frequently seen 
in MS and these are detected in 15-30% of patients 
with NMO.8 Oligoclonal bands were negative in our 
patient's CSF examination.A number of modalities 
have been tried but there is no proven treatment 
protocol as yet either in the acute attacks or in the long 
term remissions in NMO. Hence Intravenous 
corticosteroid therapy is the commonly preferred initial 
treatment for acute attacks.7 A total of 50% of the 
patients, those  who are unresponsive to corticosteroid 
treatment may benefit from plasmapheresis.7 The 
efficacy of immunomodulatory therapies 
(Beta-interferon) have not been proven yet. However, 
immunosuppressive therapy (oral azathioprine, 
associated with or without oral steroids; intravenous 
immunoglobulin; Rituximab) is an accepted method to 
provide clinical remission of corticosteroid resistant 
NMO.9Our patient received both steroid pulse therapy 
and Plasmapharesis and was sent home on oral 
steroids and azathioprine. He became fully mobile with 
no neurological deficit in the lower limbs though his 
vision was lost in the left eye 
Conclusion
NMO is a rare but severe devastating disease affecting 
vision and nervous system resulting in blindness and 
paraplegia in children. Hence an early intervention with 
the appropriate treatment modality in patients 
suspected with NMO decides on the favorable 
outcome from an acute episode
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Fig. 1a
Fig. 1b
Fig. 2a
Fig. 2b
Fig. 3
Fig 1a and b: Abnormal T2 hyper intense signals
showing post contrast enhancement predominantly
in the cervical region along with swelling of the cord
Fig 2a and b: The entire spine shows post contrast
enhancement with marked hyper intense signals in
the cervical cord
Fig 3. Shows transverse section of the cervical spine with hyper
intensities more marked posteriorly as compared to anterior cord
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INTRODUCTION 
Neuromyelitis optica (NMO) also known as Devic’s 
disease is an acute demyelinating disorder comprising 
of optic neuritis and transverse myelitis.1 NMO 
predominantly affects middle aged adults, while case 
reports from the pediatric population have been 
increasing in past few years. A recent case series of 
pediatric NMO revealed strong female predominance2. 
NMO has specific diagnostic criteria and unique 
pathologic features when compared with multiple 
sclerosis (MS) 3. Pediatric NMO has comparatively 
poor visual and motor outcomes.1Traditionally, the 
term NMO was applied to those patients who 
experienced a monophasic event consisting of bilateral 
simultaneous optic neuritis and acute myelitis.4
CASE REPORT
A 10 years old boy presented in the ER with the 
complaints of fever and back pain for past 10 days and 
inability to walk for 6-7 days. He had developed urinary 
retention and constipation for the past 5 days along 
with abdominal distension. For the past two days he 
had been complaining of blurring of vision in the left 
eye. There was no history of any recent viral illness, 
vaccination or trauma. He had been to a hospital 
where he was catheterized and started on broad 
spectrum antibiotics for the past 4 days but there was 
no improvement they came to this hospital.
 His birth and development was normal and he was a 
student of class III. There was no history of any 
allergies or surgery. Immunization was up to date. 
Family history included two sisters and three brothers 
who were well and healthy. There was no family history 
for any neurological disease or unexplained visual loss.
On examination the patient was fully alert, interactive 
and oriented. His anthropometric measures were on 
the 50th centile. He was afebrile, with stable vitals. 
There was no rash or lymphadenopathy. He was well 
hydrated and well nourished. His chest was clear with 
normal vesicular breathing while abdomen was full with 
slit like umbilicus and urinary bladder was palpable at 
the level of umbilicus, there was no shifting dullness or 
visceromegaly and gut sounds were audible. His GCS 
was 15/15 and higher mental functions were intact. 
Cranial nerves were intact. Tone was normal in all four 
limbs; power was 4/5 in both upper limbs and 1/5 in 
lower limbs. Deep tendon reflexes in upper limbs were 
+2 and in lower limbs +3. Planters were up going. 
Superficial reflexes were absent. On sensory 
examination pain, temperature, vibration and 
proprioception were intact. There were no signs of 
meningeal irritation. He was unable to sit and 
complained of pain on movement. His left eye had only 
light perception and showed rapid afferent papillary 
defect while the right eye was normal
The provisional diagnosis was Transverse myelitis 
vsNeuromyelitisoptica (NMO). Complete blood count 
and basic metabolic workup was normal. Inflammatory 
markers (C- reactive proteins and Erythrocyte 
sedimentation rate) were within normal limits. CSF 
revealed TLC 4, protein 54mg/dl, glucose 66mg/dl. 
Oligoclonal bands were negative. There was raised 
CPK. Visual evoked potential (VEP) showed 
prolongation of P100 latency along with amplitude 
loss, in left eye.MRI revealed multiple abnormal T2 
hyper intense signals showing post contrast 
enhancement almost along the entire spinal cord. 
These were predominately identified in the cervical 
region of the spinal cord along with swelling of the cord 
in this region. Overall appearance was suggestive of 
transverse myelitis. Bilateral globes and optic nerve 
appeared unremarkable. The grey matter and white 
matter appeared normalA diagnosis of Devic's disease 
was made and the patient was treated initially with 
intravenous methyl prednisolone (30 mg/kg/day for five 
days) followed by gradually tapered oral steroids. 
Condition of child remained static; therefore 
Plasmapharesis was done for 5 days. Azathioprine 2 
mg/kg/day was added and limb physiotherapy started. 
Clinical outcome was favorable with significant 
reversible of power and function of limbs. 
Discussion
By definition NMO is a monophasic or relapsing 
disorder of the optic nerves and the spinal cord, 
without evidence of white matter dysfunction of the 
brain, brainstem or cerebellum, with the exception of 
hypothalamic and lower brainstem dysfunction. Optic 
nerve and spinal cord dysfunction might be partial and 
it can be unilateral or even subclinical, with an 
abnormal visual evoked potential but no clinical signs. 
Partial forms of NMO are also called high-risk NMO, in 
which isolated transverse myelitis or optic neuritis 
occurs. The optico-spinal form of MS is quite similar to 
NMO. Hence, it appears to be a spectrum of NMO, with 
various degrees of involvement but course of NMO is 
more acute, sometimes fulminant. In contrastwith the 
optic neuritis of MS, NMO optic neuritis can be severe, 
fulminant and devastating with very poor 
prognosis.5Brain lesions have been observed in 
children; in one series 68% of NMO-IgG seropositive 
children and among them 45% had brain symptoms 
which corresponding to the MRI abnormalities6. In 
contrast to MS, attacks in NMO commonly spare the 
brain in the early stages. Hence, normal brain MRI is a 
common finding at the onset of NMO, so on follow-up 
scans must be performed periodically for development 
of later lesions in the course of the disease.4   Lesions 
in the Spinal cord are large, and extends over three or 
more vertebral segments in about 85-90% of patients 
and are mostly located in the cervical and upper 
thoracic region. The Current revised diagnostic criteria 
of NMO tells the presence of acute optic neuritis and 
myelitis with at least two of the three supportive 
criteria, which consist of spinal cord MRI lesion 
extending over three consecutive vertebral segments, 
brain MRI lesion, which does not meet the diagnostic 
criteria for multiple sclerosis, and NMO-IgG 
seropositive status.Our patient had no systemic 
disorder or non-organ-specific autoimmune disorder or 
autoantibody. At the time of the left eye's involvement, 
our patient fulfilled the diagnostic criteria.7 CSF 
examination of our patient showed no pleocytosis. 
Oligoclonal bands of IgG in the CSF are frequently seen 
in MS and these are detected in 15-30% of patients 
with NMO.8 Oligoclonal bands were negative in our 
patient's CSF examination.A number of modalities 
have been tried but there is no proven treatment 
protocol as yet either in the acute attacks or in the long 
term remissions in NMO. Hence Intravenous 
corticosteroid therapy is the commonly preferred initial 
treatment for acute attacks.7 A total of 50% of the 
patients, those  who are unresponsive to corticosteroid 
treatment may benefit from plasmapheresis.7 The 
efficacy of immunomodulatory therapies 
(Beta-interferon) have not been proven yet. However, 
immunosuppressive therapy (oral azathioprine, 
associated with or without oral steroids; intravenous 
immunoglobulin; Rituximab) is an accepted method to 
provide clinical remission of corticosteroid resistant 
NMO.9Our patient received both steroid pulse therapy 
and Plasmapharesis and was sent home on oral 
steroids and azathioprine. He became fully mobile with 
no neurological deficit in the lower limbs though his 
vision was lost in the left eye 
Conclusion
NMO is a rare but severe devastating disease affecting 
vision and nervous system resulting in blindness and 
paraplegia in children. Hence an early intervention with 
the appropriate treatment modality in patients 
suspected with NMO decides on the favorable 
outcome from an acute episode
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